scispace - formally typeset
G

Giovanni Conzo

Researcher at Seconda Università degli Studi di Napoli

Publications -  166
Citations -  3575

Giovanni Conzo is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Thyroid & Thyroidectomy. The author has an hindex of 33, co-authored 162 publications receiving 2918 citations. Previous affiliations of Giovanni Conzo include University of Naples Federico II.

Papers
More filters
Journal ArticleDOI

Minimally invasive approach for adrenal lesions: Systematic review of laparoscopic versus retroperitoneoscopic adrenalectomy and assessment of risk factors for complications

TL;DR: Laroscopic transperitoneal adrenalectomy is up to now a safe and standardized procedure with a shorter learning curve and a similar low morbidity rate, even for tumors larger than 6 cm, Nevertheless, further studies are needed to objectively evaluate these techniques.
Journal ArticleDOI

Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series.

TL;DR: As a surgical treatment of pheochromocytomas, laparoscopic adrenalectomy is an effective and safe approach, in selected cases even for PCCs >6 cm in diameter, although patients with such large tumors may have a higher conversion rate and more intraoperative hypertensive crises.
Journal ArticleDOI

Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome.

TL;DR: Patients with SS, even many years after the onset of SS, can show antibodies to pituitary and/or hypothalamic but not AVP-secreting cells, suggesting that an autoimmune process involving both the hypothalamus andpituitary gland may contribute to late pituitsary dysfunction in SS patients.
Journal ArticleDOI

Genetics of medullary thyroid cancer: An overview.

TL;DR: New genetical testings and therapeutical approaches open new perspectives in MTC management, and interesting results come from two large phase III clinical trials with two targeted tyrosine kinase inhibitors, vandetanib and cabozantinib.
Journal ArticleDOI

Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.

TL;DR: An analysis of the most recent literature data was performed to better analyze the current role of prophylactic neck dissection in the surgical treatment of papillary thyroid cancers, and concluded that only a selective use in high-risk cases is supported by more and more scientific data.